28341536|t|The role of cPLA2 in Methylglyoxal - induced cell apoptosis of HUVECs
28341536|a|Methylglyoxal (MGO), a highly reactive dicarbonyl compound, is mainly formed as a byproduct of glycolysis. Elevated MGO level is known to induce apoptosis of vascular endothelial cells, which is implicated with progression of atherosclerosis and diabetic complications. However, the underlying mechanisms have not been exhaustively investigated yet. Here, we further characterized the mechanisms how MGO induced apoptosis in human umbilical vein endothelial cells (HUVECs). Our data revealed that cytosolic phospholipase A2 (cPLA2) played an important role in MGO - induced cell apoptosis. It was found that MGO could increase both the activity and expression of cPLA2. Inhibition of cPLA2 by Pyrrophenone (PYR) or siRNA significantly attenuated the MGO - induced apoptosis. Additionally, MGO time - dependently decreased the phosphorylation of nuclear factor κB (NF-κB). Pretreatment of the cells with NF-κB inhibitor, BAY11-7082, further increased MGO - induced apoptosis of HUVECs, indicating that NF-κB played a survival role in this MGO - induced apoptosis. Furthermore, in the presence of si-cPLA2 or PYR, MGO no longer decreased NF-κB phosphorylation. Beyond that, the antioxidant N-acetyl cysteine (NAC) could reverse the changes of both cPLA2 and NF-κB caused by MGO. p38, the upstream of cPLA2, was also significantly phosphorylated by MGO. However, p38 inhibitor failed to reverse the apoptosis induced by MGO. This study gives an important insight into the downstream signaling mechanisms of MGO, cPLA2 - NF-κB, in endothelial apoptosis.
28341536	12	17	cPLA2	T103	UMLS:C1333201
28341536	21	34	Methylglyoxal	T103	UMLS:C0034338
28341536	45	59	cell apoptosis	T038	UMLS:C0162638
28341536	63	69	HUVECs	T017	UMLS:C3179121
28341536	70	83	Methylglyoxal	T103	UMLS:C0034338
28341536	85	88	MGO	T103	UMLS:C0034338
28341536	109	128	dicarbonyl compound	T103	UMLS:C0574031
28341536	165	175	glycolysis	T038	UMLS:C0017952
28341536	186	189	MGO	T103	UMLS:C0034338
28341536	215	224	apoptosis	T038	UMLS:C0162638
28341536	228	254	vascular endothelial cells	T017	UMLS:C1257792
28341536	296	311	atherosclerosis	T038	UMLS:C0004153
28341536	316	338	diabetic complications	T038	UMLS:C0342257
28341536	470	473	MGO	T103	UMLS:C0034338
28341536	482	491	apoptosis	T038	UMLS:C0162638
28341536	495	533	human umbilical vein endothelial cells	T017	UMLS:C3179121
28341536	535	541	HUVECs	T017	UMLS:C3179121
28341536	567	593	cytosolic phospholipase A2	T103	UMLS:C1333201
28341536	595	600	cPLA2	T103	UMLS:C1333201
28341536	630	633	MGO	T103	UMLS:C0034338
28341536	644	658	cell apoptosis	T038	UMLS:C0162638
28341536	667	672	found	T033	UMLS:C0150312
28341536	678	681	MGO	T103	UMLS:C0034338
28341536	706	714	activity	T038	UMLS:C0243102
28341536	719	729	expression	T038	UMLS:C1171362
28341536	733	738	cPLA2	T103	UMLS:C1333201
28341536	754	759	cPLA2	T103	UMLS:C1333201
28341536	763	775	Pyrrophenone	T103	UMLS:C1136555
28341536	777	780	PYR	T103	UMLS:C1136555
28341536	785	790	siRNA	T103	UMLS:C1099354
28341536	820	823	MGO	T103	UMLS:C0034338
28341536	834	843	apoptosis	T038	UMLS:C0162638
28341536	859	862	MGO	T103	UMLS:C0034338
28341536	896	911	phosphorylation	T038	UMLS:C0031715
28341536	915	932	nuclear factor κB	T103	UMLS:C0079904
28341536	934	939	NF-κB	T103	UMLS:C0079904
28341536	962	967	cells	T017	UMLS:C0007634
28341536	973	978	NF-κB	T103	UMLS:C0167954
28341536	979	988	inhibitor	T103	UMLS:C0243077
28341536	990	1000	BAY11-7082	T103	UMLS:C0969281
28341536	1020	1023	MGO	T103	UMLS:C0034338
28341536	1034	1043	apoptosis	T038	UMLS:C0162638
28341536	1047	1053	HUVECs	T017	UMLS:C3179121
28341536	1071	1076	NF-κB	T103	UMLS:C0079904
28341536	1108	1111	MGO	T103	UMLS:C0034338
28341536	1122	1131	apoptosis	T038	UMLS:C0162638
28341536	1165	1173	si-cPLA2	T103	UMLS:C1333201
28341536	1177	1180	PYR	T103	UMLS:C1136555
28341536	1182	1185	MGO	T103	UMLS:C0034338
28341536	1186	1205	no longer decreased	T033	UMLS:C0243095
28341536	1206	1211	NF-κB	T103	UMLS:C0079904
28341536	1212	1227	phosphorylation	T038	UMLS:C0031715
28341536	1246	1257	antioxidant	T103	UMLS:C0003402
28341536	1258	1275	N-acetyl cysteine	T103	UMLS:C0001047
28341536	1277	1280	NAC	T103	UMLS:C0001047
28341536	1316	1321	cPLA2	T103	UMLS:C1333201
28341536	1326	1331	NF-κB	T103	UMLS:C0079904
28341536	1342	1345	MGO	T103	UMLS:C0034338
28341536	1347	1350	p38	T103	UMLS:C1451465
28341536	1356	1364	upstream	T082	UMLS:C0522505
28341536	1368	1373	cPLA2	T103	UMLS:C1333201
28341536	1398	1412	phosphorylated	T038	UMLS:C0031715
28341536	1416	1419	MGO	T103	UMLS:C0034338
28341536	1430	1433	p38	T103	UMLS:C1451465
28341536	1434	1443	inhibitor	T103	UMLS:C0243077
28341536	1466	1475	apoptosis	T038	UMLS:C0162638
28341536	1487	1490	MGO	T103	UMLS:C0034338
28341536	1497	1502	study	T062	UMLS:C2603343
28341536	1539	1549	downstream	T082	UMLS:C0522506
28341536	1550	1570	signaling mechanisms	T038	UMLS:C0037080
28341536	1574	1577	MGO	T103	UMLS:C0034338
28341536	1579	1584	cPLA2	T103	UMLS:C1333201
28341536	1587	1592	NF-κB	T103	UMLS:C0079904
28341536	1597	1608	endothelial	T017	UMLS:C0225336
28341536	1609	1618	apoptosis	T038	UMLS:C0162638